Status:
NOT_YET_RECRUITING
China Hypertension and Diabetes Care Cascade Study
Lead Sponsor:
Peking Union Medical College
Conditions:
Hypertension
Diabetes
Eligibility:
All Genders
35-74 years
Phase:
NA
Brief Summary
This implementation study aims to identify priorities and formulate strategies to overcome health service delivery bottlenecks associated with hypertension and diabetes in rural China. Leveraging impl...
Detailed Description
Hypertension and type 2 diabetes present substantial challenges to the Chinese health system. A nationwide survey revealed a hypertension prevalence of 37.2% among Chinese adults over 35, with only 44...
Eligibility Criteria
Inclusion
- Permanent residents of the surveyed village (residing for more than six months each year).
- Age between 35 and 74 years old.
Exclusion
- Individuals with severe mental disorders or communication barriers.
- Individuals planning to move out of the village within the next year.
- Expected life expectancy of less than one year.
- Pregnant or lactating individuals.
- Individuals who are currently away (i.e. hospitalized, or residing elsewhere) so that cannot participate in the survey.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
14400 Patients enrolled
Trial Details
Trial ID
NCT06141278
Start Date
January 1 2024
End Date
December 31 2026
Last Update
November 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.